DK255190A - Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader - Google Patents

Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader Download PDF

Info

Publication number
DK255190A
DK255190A DK255190A DK255190A DK255190A DK 255190 A DK255190 A DK 255190A DK 255190 A DK255190 A DK 255190A DK 255190 A DK255190 A DK 255190A DK 255190 A DK255190 A DK 255190A
Authority
DK
Denmark
Prior art keywords
certain
procedures
paf antagonist
combinations
antihistamine
Prior art date
Application number
DK255190A
Other languages
Danish (da)
English (en)
Other versions
DK255190D0 (da
Inventor
M Motasim Billah
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK255190A publication Critical patent/DK255190A/da
Publication of DK255190D0 publication Critical patent/DK255190D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK255190A 1988-04-27 1990-10-23 Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader DK255190D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18653588A 1988-04-27 1988-04-27
PCT/US1989/001671 WO1989010143A1 (en) 1988-04-27 1989-04-24 Certain paf antagonist antihistamine combinations and methods

Publications (2)

Publication Number Publication Date
DK255190A true DK255190A (da) 1990-10-23
DK255190D0 DK255190D0 (da) 1990-10-23

Family

ID=22685331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK255190A DK255190D0 (da) 1988-04-27 1990-10-23 Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader

Country Status (15)

Country Link
EP (2) EP0402422A1 (ja)
JP (1) JPH0655673B2 (ja)
KR (1) KR930009786B1 (ja)
AT (1) ATE84724T1 (ja)
AU (1) AU619555B2 (ja)
CA (1) CA1327316C (ja)
DE (1) DE68904475T2 (ja)
DK (1) DK255190D0 (ja)
ES (1) ES2044100T4 (ja)
IE (1) IE63697B1 (ja)
IL (1) IL90100A (ja)
MY (1) MY106956A (ja)
NZ (1) NZ228879A (ja)
WO (1) WO1989010143A1 (ja)
ZA (1) ZA893101B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
DE69113162T2 (de) * 1990-08-02 1996-03-14 Hoffmann La Roche Antiallergische Mischung.
US5227378A (en) * 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Also Published As

Publication number Publication date
JPH03502097A (ja) 1991-05-16
AU3578289A (en) 1989-11-24
IE891362L (en) 1989-10-27
ZA893101B (en) 1989-12-27
DK255190D0 (da) 1990-10-23
IE63697B1 (en) 1995-05-31
MY106956A (en) 1995-08-30
IL90100A (en) 1995-01-24
EP0345931A1 (en) 1989-12-13
ATE84724T1 (de) 1993-02-15
NZ228879A (en) 1992-08-26
CA1327316C (en) 1994-03-01
ES2044100T3 (es) 1994-01-01
KR930009786B1 (ko) 1993-10-11
DE68904475D1 (de) 1993-03-04
JPH0655673B2 (ja) 1994-07-27
KR900700136A (ko) 1990-08-11
ES2044100T4 (es) 1996-07-16
DE68904475T2 (de) 1993-05-13
IL90100A0 (en) 1989-12-15
EP0402422A1 (en) 1990-12-19
WO1989010143A1 (en) 1989-11-02
EP0345931B1 (en) 1993-01-20
AU619555B2 (en) 1992-01-30

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
IE831613L (en) Heterocyclyl piperidine compounds
DE3885816T2 (de) Mischungen von Polycarbonat und von Siloxan-Polyetherimid-Copolymer.
DE3883786T2 (de) Laserwiedergabegerät.
DE68906345T2 (de) Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
DE3866038D1 (de) Bohrer und zugehoeriger schneideinsatz.
DK255190D0 (da) Visse paf-antagonist/antihistamin-kombinationer og fremgangsmaader
DE69116705T2 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
DE384953T1 (de) Huepfspiel und dessen spielart.
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
ES544787A0 (es) Preparaciones medicinales solidas
DE3887345T2 (de) Fluoriertes copolymer und sperrschichten.
DK0669394T3 (da) Bifunktionelle urokinasevarianter med forbedrede fibrinolytiske egenskaber og thrombinhæmmende virkninger
NO893892D0 (no) Antimikrobiologisk sammensetning og fremgangsmaate for anvendelse.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
NO883927L (no) Staal og anvendelse av dette.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
FI896159A0 (fi) Valsanordning med en undervals med hydrauliskt innerstoed.
ATE114464T1 (de) Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
DE68910057D1 (de) Behandlungszusammensetzungen.
DE58902310D1 (de) Tetrahydropyridin-derivate.
FI883268A0 (fi) Engaongssugpaose foer patientsekret.
NO890097D0 (no) Liposom/doksorubicin-sammensetning og fremgangsmaate.
NO890035L (no) Colepteran-aktive mikroorganismer, relaterte insekticid-sammensetninger og fremgangsmaater og anvendelse derav.
NO880738L (no) Blokkpolymer og anvendelse av denne.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment